Alisha Alaimo is the current President of Biogen U.S. Organization at Biogen. Alisha has held various positions at Novartis Pharmaceuticals, Alcon, and Johnson & Johnson. Alisha has been in the pharmaceutical industry for over 20 years and has a wealth of experience in managing businesses and teams.
Alisha Alaimo graduated from Emory University with a Bachelor of Science in Biology.
Their manager is Michel Vounatsos, CEO & Board Director. Alisha Alaimo works with Wolfram Schmidt - President, Europe, Canada & Partner Markets, Nicole Murphy - Head of Pharmaceutical Operations & Technology, and Ginger Gregory - EVP, CHRO.
Current role
October, 2017